Table 2.

Published trials using third-party virus-specific T cells to treat EBV lymphoma

Activation method	Patients	CR or PR	Failure	GVHD	ORR	References
LCL-induced	33 (includes SOT)	17	16	None	52%	Haque et al, 200741
	57	36	18	None	63%	Prockop et al, 201542
	10 (includes SOT)	8	2	None	80%	Vickers et al, 201424
	9	6	3	2	67%	Leen et al, 201325
	4	1	3	1	25%	Naik et al, 201643
Pepmix-induced	2	1	1	None	50%	Naik et al, 201643
Multimer-selected	1	1	0	None	100%	Uhlin et al, 201044

LCL, lymphoblastoid cell lines; SOT, post-solid organ transplantation.